115 related articles for article (PubMed ID: 22041223)
1. Inhibition of α folate receptor resulting in a reversal of taxol resistance in nasopharyngeal carcinoma.
Li W; Tan G; Ma Y; Li H; He G
Otolaryngol Head Neck Surg; 2012 Feb; 146(2):250-8. PubMed ID: 22041223
[TBL] [Abstract][Full Text] [Related]
2. [Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells].
Li W; Tan GL; Ma YH; Peng XW; He GX
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 45(12):1035-40. PubMed ID: 21215055
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of taxol-resistant nasopharyngeal carcinoma cells with siRNA-mediated FOLR1 downregulation.
Song Y; Peng X; Wang M; Xie J; Tan G
Int J Clin Exp Pathol; 2015; 8(9):11314-22. PubMed ID: 26617855
[TBL] [Abstract][Full Text] [Related]
4. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
5. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
6. Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.
Li W; You Y; Zhang X; Song Y; Xiang H; Peng X; Qin J; Tan G
Int J Clin Exp Pathol; 2015; 8(10):12346-56. PubMed ID: 26722421
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
8. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
[TBL] [Abstract][Full Text] [Related]
9. Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance.
Zhang X; Li W; Li H; Ma Y; He G; Tan G
Anticancer Drugs; 2012 Sep; 23(8):856-64. PubMed ID: 22824824
[TBL] [Abstract][Full Text] [Related]
10. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
11. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
[TBL] [Abstract][Full Text] [Related]
12. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells.
Zhang X; Wang Q; Ling MT; Wong YC; Leung SC; Wang X
Int J Cancer; 2007 May; 120(9):1891-8. PubMed ID: 17230521
[TBL] [Abstract][Full Text] [Related]
14. [Differential expression of taxol resistance and taxol resistance reversal related genes in nasopharyngeal carcinoma by cDNA microarray].
Peng X; Tan G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):48-52. PubMed ID: 22349379
[TBL] [Abstract][Full Text] [Related]
15. miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1.
Huang L; Hu C; Chao H; Wang R; Lu H; Li H; Chen H
Exp Cell Res; 2019 May; 378(1):1-10. PubMed ID: 30779921
[TBL] [Abstract][Full Text] [Related]
16. Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma.
Ren S; Li G; Liu C; Cai T; Su Z; Wei M; She L; Tian Y; Qiu Y; Zhang X; Liu Y; Wang Y
Oncol Rep; 2016 Oct; 36(4):1861-7. PubMed ID: 27498905
[TBL] [Abstract][Full Text] [Related]
17. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells.
Chi HM; Du JD; Cheng J; Mao HD
Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069
[TBL] [Abstract][Full Text] [Related]
18. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
Zuo Q; Luo RC
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
[TBL] [Abstract][Full Text] [Related]
20. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
Liu Z; Jin X; Pi W; Liu S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29070520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
